Neonc Technologies Holdings, Inc.
- NTHI
- NASDAQ
- Biotechnology
- Clinical-Stage Biotech (CNS)
- CNS Drug Delivery
$2.70
Today −1.82%Quote Oct 16, 2026, 08:00 PM UTC
−20.82%over the last month
Max drawdown −26.7%From 1-month high −21.7%3 months −17.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$70.0M
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$16.00
+492.6% from here
Floor
$2.50
7.4% below price
Where the price sits
1 analyst
Analyst range, low to high
$13.00$20.00
- Price $2.70
- Resistance $2.80
- Consensus $16.00
Analysts' average target sits about 493% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NTHIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
5
Founded
2008